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Editorial
The Decision Is In - Now What?
By David B. Nash, MD, MBA
Editor-in-Chief

Because this is the final issue in our
series featuring multistakeholder
viewpoints on health care reform, it is
only fitting that I devote my editorial
to the singular event that colored every
article - the Supreme Court decision
regarding the constitutionality of the
Patient Protection and Affordable
Care Act (ACA).
Of all the commentary I read on
the topic, Time Magazine’s “Special
Report: The Health Care Decision”
struck me as the most balanced and
comprehensive. Lead author David
Von Drehle’s analysis of the legal
gymnastics that turned a potential
zero-sum game into a win-win
situation was fascinating, as was his
profile of the man behind the decision,
Chief Justice John Roberts.1
Controversies will continue to foment,
but 2 things are certain: (1) Health care
reform as laid out in the contentious
ACA is constitutional, and (2) Congress
“may not hold states hostage to its every
whim,” (ie, the federal government
cannot force states to adopt the Medicaid
expansion provision, a key element in the
pursuit of universal coverage).

So, what does this mean for the average
American beginning in 2014?
For the first time in our history, almost
everyone will be required to have
health insurance. The most notable
exceptions are those for whom available
coverage options would exceed 8% of
their income. Insurers will be required
to price and sell policies to everyone,
regardless of their health status. For
young adults older than age 26, it
means paying a financial penalty for
being uninsured. For low- to middleincome earners, it means the possibility
of qualifying for state Medicaid
programs or federal subsidies to help
pay for health insurance. For those with
“preexisting conditions,” it means that
insurance companies will be prohibited
from denying insurance and charging
higher prices. Because insurers will be
Prescriptions for Excellence in Health
Care is brought to Population Health
Matters readers by Jefferson School
of Population Health in partnership
with Lilly USA, LLC to provide
essential information from the quality
improvement and patient safety arenas.

(continued on page 2)
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barred from setting premiums based
on risk, it is likely that we all will pay
a little more for our health coverage.

likely will have its most intense effect
in the political arena, the upcoming
presidential election in particular.

The law includes some taxes on
industries that are expected to gain
from it (eg, medical device makers,
pharmaceutical companies). It raises
the Medicare tax rate for families
earning more than $250,000 a year
and cuts some Medicare spending
(eg, reduced reimbursement for the
costlier than estimated Medicare
Advantage program). Although such
taxes and cuts are never popular, they
are good policy.

The health economic piece may
prove to be the biggest challenge. As
economics professor Christina D.
Romers observed in her New York
Times article, “Only the First Step in
Containing Health Costs,”2 serious
discussion of additional cost-saving
measures may be a long way off.
The reason: Instead of focusing on
ways to make the entire health care
system more efficient, Republicans
seem more interested in limiting the
government’s share of health care
expenditures and Democrats seem
more interested in preserving existing
government programs.

Whether in the government or private
sector, those of us who are engaged in
health care administration and delivery
will continue to work to implement
the ACA’s ambitious, broad-reaching
reforms. Some entities will almost
certainly continue to undermine reform
efforts; for example, will the 26 states
that challenged the Medicaid expansion
provision of the ACA now opt out
and, if so, how many millions will
remain without coverage? The decision

Given the foregoing “backdrop,” I
think that the 3 articles in this issue
wrap up the series perfectly. The
first, “The Supreme Court and Health
Reform: A Practical Perspective,” is
a very timely and comprehensive
discussion of the ACA - from its
passage, to the Supreme Court

decision, to its implications for
all stakeholders. “A Perspective:
Through the Eye of the Beholder –
Gauging Health Care Value” makes
a compelling case for understanding
the core components of “value,”
with particular emphasis on the
often overlooked patient/consumer
perspective. At first glance, the final
article, “A Black Swan Comes to
Philadelphia,” may seem like mere
whimsical exaggeration. But, without
the kind of health care system reforms
initiated by the ACA, it may become
a painful reality.
As always, I welcome comments,
suggestions, and questions from
our readers. I can be reached at:
david.nash@jefferson.edu
References
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A Message from Lilly
Health Care Reform – Are all the Laws Being “Reformed”?
By Steven C. Benz, Esq.
For the past few months, focus has
been on the Supreme Court and what
it might say regarding the Affordable
Care Act (ACA). Now that it has
made its decision, what’s next? The
first thing to consider is that health
care reform is more of a continuing
effort than simply an event. Given
current politics, new technologies, and
a volatile economy, ongoing reform
may be the “new normal.”

Going forward, the legal community
will be called upon to interpret the
continuous change as companies make
business decisions and to counsel
clients on how to be compliant in
this evolving landscape. The latter
point is complicated by a legal system
wherein the laws governing how
companies are to behave often lag
behind the realities of the health care
environment (an environment that

increasingly is being shaped by the
government through laws such as
ACA). In many instances, laws were
written to address circumstances that
are no longer relevant or nonexistent.
It follows that another role of the
health care lawyer is to assess where
and how laws can be reformed.
Before discussing some laws that
need updating to further reform, it is
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important to note that such hopeful
changes will take time. So what
should be done in the short run?
In order to deal with continuous
change, the key is to stay grounded
and avoid making legal concepts
any more complicated than they are.
Many basic concepts that predate
the ACA will continue throughout
all of the reforms.
As a rule, the following points are
at issue: (1) Is the right patient
getting the right treatment? (2)
Are providers getting the right
information in order to make the
best decisions for the patient? (3)
Are payers paying what they should?
(4) Are the financial relationships
between the players in the health
care sector appropriate and not
creating incentives for bad behavior?
In the absence of clear guidance, if a
contemplated action causes anxiety
with respect to the 4 points above, it
certainly requires further scrutiny by
a legal team and, beyond that, simply
may not be the right thing to do.
Our continuous health care reform
has not changed any of the above but
it has made the situation more acute.
In particular, as the government

plays a larger role, federal and state
fiscal challenges will continue.
Approximately 10,000 people turn
age 65 every day. Costs will continue
to rise and those who pay those costs
will wonder how the money is being
spent. This leads to an increased
emphasis on compliance.
What laws need reform? We
need laws that allow for more
collaboration between the
participants in the health care
industry rather than less. An example
of a positive action along those
lines is the effort by the Centers for
Medicare and Medicaid Services
and the Office of the Inspector
General to develop fraud and
abuse waivers for certain beneficial
Accountable Care Organization
arrangements. On a less positive
note, many potential opportunities
between the pharmaceutical industry
and providers may be missed when
an industry member cannot find
a way to enter into a program
with a provider and still be able to
account for it in its Government
Price Reporting in the Medicaid
and Medicare programs, if required.
Steps must be taken to assure that
new scientific information is relayed
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quickly and thoroughly to provide
decision makers with the most
complete information available.
A vibrant marketplace where
participants have financial incentives
to do better is a great way to improve
the abilities of all involved. However,
some are concerned that such
incentives may lead to bad behavior.
Often these fears lead policy makers
and enforcement agencies to create
and enforce laws that curtail the
“right” behaviors to promote good
health care. For this reason, some laws
actually may be prohibiting reform
or moving further away from it. To
overcome such skepticism, different
stakeholders in the health care sector
must agree on a best practice (that
existing laws may be preventing)
and work together to create legal
reform. This reform could allow
innovative practices to spring forward,
benefitting the health care system and
the patients its serves.
Steven C. Benz, Esq., is Assistant
General Counsel, Managed Healthcare
Services and Governmental Affairs for
Eli Lilly and Company.

The Supreme Court and Health Reform: A Practical Perspective
By Howard A. Burde, Esq.
On June 28, 2012, the US Supreme
Court issued its holding in the initial
challenges to the constitutionality of
the Patient Protection and Affordable
Care Act (“ACA”) in the case of National
Federation of Independent Business (NFIB)

et al v. Sebelius (Slip Opinion of Case 11393 on certiorari to the Supreme Court.)
This decision will dramatically impact
both the future of the nation’s health and
the nature of relationships for US health
care programs.

The 900-page ACA legislation (or
“Obamacare” as it is known, derisively or
colloquially depending upon the user’s
political perspective) promised to extend
universal health insurance coverage to all
(continued on page 4)
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Americans and was touted as the
long-awaited health reform to cure
manifest problems with cost, access,
and perverse incentives in the health
care system. In reality, it was and
is far less. In fairness, it was and is
a consequential attempt to extend
health insurance coverage to a large
number of adults formerly not covered
by insurance, either by choice or
circumstance. However, the ACA
provides little in the way of systemic,
structural, or payment reform. Thus,
the ACA is about coverage, not
reform. The purpose of this article is to
describe the components of the ACA
at issue in the NFIB v. Sibelious, and to
discuss the implications of the decision
on the ACA itself, state and federal
governments, consumers, employers,
providers, and payers.
Background
The ACA attempts to increase access
to health insurance coverage while
expanding federal and private health
insurance market requirements,
and requires the creation of health
insurance exchanges (HIEs) to provide
individuals and small employers with
access to insurance. Among other
provisions, ACA increases access to
health insurance coverage by: (1)
expanding Medicaid eligibility by
mandating that individuals obtain
health coverage and that employers
provide it, (2) extending funding
for the Children’s Health Insurance
Program (CHIP), and (3) subsidizing
private insurance premiums and cost
sharing for certain lower-income
individuals enrolled in exchange plans.
These costs are projected to be offset
by increased taxes and other revenues
and reduced Medicare and Medicaid
spending. The law also includes
measures to collect information and to
explore new ways to enhance delivery
and quality of care.

The major expansion and reform
provisions in ACA take effect in
2014. State Medicaid programs will
be required to expand coverage to all
eligible nonpregnant, non-elderly legal
residents with incomes up to 133%
of the federal poverty level (FPL).
The actual percentage works out to be
138% because the first 5% of income
is disregarded for Medicaid eligibility
determinations. The federal government
will initially cover all the costs for
this group, with the federal matching
percentage phased down to 90% of the
costs by 2020. The law requires states
to maintain the current CHIP structure
through fiscal year (FY) 2019, and
provides federal CHIP appropriations
through FY2015, thus extending CHIP
funding by 2 years.
States are incentivized to establish HIEs
that provide access to private health
insurance plans with standardized benefit
and cost-sharing packages for eligible
individuals and small employers. In
2017, states may allow larger employers
to purchase health insurance through
the exchanges, but are not required to
do so. The Secretary of Health and
Human Services (HHS) is empowered
to establish HIEs in states that do not
create their own approved exchange.
Premium credits and cost-sharing
subsidies will be available to individuals
who enroll in HIE plans, provided their
income is generally above 100% and
no more than 400% of the FPL and
they meet other requirements. Also
beginning in 2014, most individuals will
be required to have health insurance
or pay a tax penalty (the “individual
mandate”). Employers with more than
50 employees that do not offer health
insurance may be subject to penalties.
Such employers that do not meet the
law’s requirement by offering qualified
health insurance products, or whose

full-time workers enroll in HIE plans
and receive premium subsidies, will pay
a penalty.
ACA’s federal health insurance
requirements are further expanded
in 2014, with no annual dollar limits
permitted on essential health benefits
and no exclusions permitted for
preexisting conditions or the patient’s
age. Plans offered within HIEs and
certain other plans also must meet
criteria of essential benefit standards (eg,
covering emergency services, hospital
care, physician services, preventive
services, prescription drugs, and mental
health and substance use disorder
services). Premiums may vary by limited
amounts based on age (3:1), family size,
geographic area, and tobacco use (1.5:1).
Plans must sell and renew policies to all
individuals and may not discriminate
based on health status.
Employers face additional – and costly –
new requirements such as new increases
in benefits and premium costs, and new
taxes on premiums passed through to
employers. Moreover, the ACA contains
a number of new “soft costs” that are
rarely discussed in the public arena but
which add significantly to the employer
burden regardless of the insurance
changes (eg, withholding changes,
mandates for reporting the value of
health coverage, uniform summary of
benefits and coverage, summaries of
material modifications, auto-enrollment,
new taxes on high earners, new taxes on
high-benefit plans).
(Note: The material in the foregoing
section is derived from the language
of the ACA and from Congressional
Research Services reports, most
notably PPACA: A Brief Overview of
the Law, Implementation, and Legal
Challenges [Chaikind H, et al. CRS
March 2, 2011].)

This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC.

Prescriptions for Excellence in Health Care
Summary of the Supreme Court’s Decision in
NFIB v. Sebelius
The Supreme Court considered
4 questions:
1. Does the Anti-Injunction Act
preclude consideration of the
mandate as a tax prior to 2014?
2. Is it constitutional for Congress to
mandate that all individuals purchase
or maintain health coverage?
3. If the mandate were unconstitutional,
would it be severable from the
remainder of the ACA, or would the
entire Act be unconstitutional?
4. Is the Medicaid expansion under the
ACA constitutional?
Initially, the Supreme Court held that
the Anti-Injunction Act does not
preclude consideration of the mandate
as a tax because Congress called the
mandate a penalty.
Having satisfied the threshold question,
the Supreme Court decided that the
individual mandate was unconstitutional
under Congress’ Commerce Clause
powers, but that it could be read as a tax
and therefore was constitutional under
Congress’s power to tax and spend. This
is the most controversial component of
the decision. Indeed, only Chief Justice
Roberts held this opinion. Four Justices
agreed that the individual mandate was
unconstitutional under the Commerce
Clause (Kennedy, Scalia, Alito, and
Thomas), making a majority for that
part of the Chief Justice’s decision. Even
though they believe it is constitutional
under the Commerce Clause, the 4
other Justices (Ginsberg, Breyer, Kagan,
and Sotomayor) agreed to uphold the
individual mandate as a tax, making a

majority opinion to uphold the individual
mandate. Because the individual mandate
was ruled constitutional, the severability
question was moot.
Finally, the court held that Congress
could not condition a state’s receipt of
funds for an existing program on the
expansion of that program or a new
program. Therefore, the Medicaid
expansion to new populations was ruled
to be unconstitutional if mandatory for
states. States may opt to expand, but
cannot be forced to do so.
What the Supreme Court’s Decision Means
The Individual Mandate
To understand the Court’s decision, it
is helpful to understand the underlying
provision of the Constitution. The
opening paragraph of Article I, Section
8, which provides the powers of
Congress, states that, “Congress shall
have the power to lay and collect taxes,
duties, imposts and excises, to pay the
debts and provide for the common
defense and general welfare of the
United States.” Several additional clauses
“enumerate” the powers of Congress to
which the opening paragraph applies,
and among these enumerated powers
is the power under Article I, Section 8,
Clause 3, to “regulate commerce with
foreign nations and among the several
states and with Indian tribes.” This is
known as the “Commerce Clause.”
In defending the mandate, Congress
and the Obama administration asserted
that the Commerce Clause was plenary
and without limitation because every
act or non-act would impact commerce.
Indeed, the history of the Supreme Court
Commerce Clause jurisprudence since the
New Deal is one of steady expansion of
Congress’ authority to regulate under the
Commerce Clause. Chief Justice Roberts
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noted that “the power of Congress over
interstate commerce is not confined to
the regulation of commerce among the
states but extends to activities that ‘have a
substantial effect on interstate commerce.’”
The Chief Justice further noted that
Congress’s power is “not limited to the
regulation of an activity that by itself
substantially affects interstate commerce,
but also extends to activities that do so
only when aggregated with the activities
of others.” “But,” the Chief Justice
noted, “Congress has never attempted to
rely on that power to compel individuals
not engaged in commerce to purchase an
unwanted product.”
The court held that the power to regulate
commerce “presupposes the existence
of commercial activity to be regulated.”
There must be actual activity and
Congress does not have the authority
to compel activity to then regulate.
Moreover, the Chief Justice held that
Congress cannot regulate individuals
because they are not engaged in an
activity, or as he stated, “doing nothing.”
“Every day individuals do not do an
infinite number of things” and “Congress
is not empowered to regulate that
absence of activity or to mandate activity
under the Commerce Clause.”
By contrast, Congress’ power to lay and
collect taxes is considered plenary. It is
accepted jurisprudence that Congress’
power to tax is virtually unlimited
constitutionally, but is generally limited
politically. The Chief Justice notes that
the ACA does not describe the penalty
for not having health coverage as a tax.
Indeed, central to the political debate
leading to passage of the law was the
insistence of Congress and the President
that the law did not raise taxes, but that
the mandate was a “shared responsibility
payment.” The fear, of course, was that
(continued on page 6)
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if the mandate were considered a tax, it
would have been more difficult to get the
votes to pass the bill.
On July 24, 2012, the Congressional
Budget Office announced that the
decision itself changed the tax calculus to
add $4 billion in new taxes on businesses
and $1.5 billion in new taxes for
individuals. In fact, ACA raises over $1
trillion in taxes, inclusive of the mandate
being a tax, and diverts over $500 billion
from the Medicare program.
Ultimately, this part of the decision
means that the mandate tax is now
subject to a simple calculus for
individuals. The question becomes one
of whether it is more cost-effective
to obtain coverage in advance or to
risk paying the penalty and obtain the
coverage only when needed. Because
of the guaranteed issue provisions of
the ACA, an individual can obtain
coverage at any time. Without an
enforceable law, there is only a tax
to compel an individual to obtain
coverage prior to an illness.
In a broader sense, the holding means
that future expansions of federal authority
likely would be justified as constitutional
under the taxing and spending power, a
higher bar to reach politically.
Medicaid Expansion
The Supreme Court also held that
Congress could not mandate state
expansion of the Medicaid program
to new populations. Recall that half
of the anticipated additional coverage,
approximately 16 million lives, would
have been through the Medicaid
program. Given the problems with
the Medicaid program as currently
structured, 27 states representing
approximately 40% of the anticipated
new lives challenged the expansion.

Although politics may have played some
part in the challenge, the Medicaid
programs in most states are problematic
from both administrative and budget
perspectives. Even with a federal
promise to pay for the increase of nearly
all of the Medicaid expansion in the
short term, adding 16 million more
lives to the program was and is not
considered practical for the governors of
those states.
The Supreme Court’s decision validated
the challenge, reviving a state’s ability to
determine whether or not to participate
in a federally funded program. To date,
7 states with 20% of the anticipated new
lives to be covered have already opted
out and another 9 are considered likely
to do so. Two reasons predominate.
First, the federal promise of full funding
is ephemeral. Once an entitlement is in
place it cannot be withdrawn without
a huge political and legal battle. If the
federal money were to be reduced,
the states would be stuck with the bill
and forced to either generate revenue
through taxes or reduce other programs
(eg, infrastructure, transportation,
education) to pay for the federal
mandate. State budgets are littered with
unfunded or partially funded federally
mandated programs. Adding another at
a time when state budgets are already
stressed makes no fiscal sense. Second,
the limited budget reduction proposals
from the Obama administration
already call for a reduction of federal
financial participation for the Medicaid
expansion and for CHIP participation.
Even though the Obama administration
has not passed a budget for 3 fiscal
years, it has already signaled to the
states that the federal matching funds
are at risk. Under such circumstances,
it can be argued that implementation
of the Medicaid expansion is political,
while declining to do so is pragmatic.

The Supreme Court’s decision on
the Medicaid expansion has further
implications for the relationship between
the federal and state governments.
Programs such as nutrition, education,
transportation, aging, and Medicaid
are administered by states under
formulas that include federal financial
participation. The states must submit
extensive “State Plans” for federal
approval in order to draw down the
federal funds. The states also file for
waivers from federal requirements in
order to run the programs in more
effective ways. By limiting the federal
leverage over states, the Supreme Court
has created the opportunity for states to
seek federal funds without significant
bureaucratic conditions and with
dramatically new structures.
The states argue that, being closer to the
delivery of services, they know how to
best deploy the resources without a layer
of bureaucratic oversight. Indeed, there
is no evidence that state bureaucrats are
any less educated, dedicated, or able than
federal ones. State bureaucrats simply
work for less money in less exciting
places. Effectively, the Court’s decision
creates the conditions for a new balance
of federal and state authority with respect
to federally funded programs. Note
that several states are in the process of
structuring alternatives to the Medicaid
expansion for federal consideration.
These alternatives may include revised
benefit structures for both the new and
existing components of the Medicaid
population, such as the expansion of
existing but less expensive programs
like SCHIP, mini-med or catastrophic
programs, or yet undetermined choices.
This leads to issues of the flexibility of
the ACA language to permit alternative
structures and the willingness of the
Department of HHS to grant waivers
for restructuring. Ultimately, the
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ability to offer alternatives is a positive
opportunity to reach toward universal
coverage without undermining state
fiscal structures.
Impact on Consumers and Employers
The net impact of the Supreme Court
decision on consumers is to make the
individual mandate less compelling.
Because the tax is both low and not
subject to enforcement, there is little
to compel individuals to purchase
insurance before they need it. The
annual tax for not having minimum
essential coverage will be the greater of
a flat dollar amount per individual or a
percentage of the individual’s taxable
income. For any dependent younger
than age 18, the penalty is one half
of the individual amount. The flat
dollar amount per individual is $95 in
2014; $325 in 2015, and $695 in 2016.
After 2016, the flat dollar amount is
indexed to inflation. The flat dollar
penalty is capped at 300% of the flat
dollar amount. The percentage of
taxable income is an amount equal to
a percentage of a household’s income
(as defined by the Act) that is in excess
of the tax filing threshold (phased
in at 1% in 2014; 2% in 2015; 2.5%
in 2016). The tax will be reflected as
a federal tax liability on income tax
returns and is enforced by the Treasury.
Individuals who fail to pay the
penalty will not be subject to criminal
penalties, liens, or levies.
The essential benefit packages mandated
by the ACA are very rich and include
the costs associated with taxes on
medical devices, on premiums, and on
executive policies. So, individuals have a
choice: They can purchase a rich benefit
package with associated taxes from day
1, or risk paying a small tax and either
purchase the insurance as they need it
or purchase less expensive but adequate
coverage outside the HIEs.

If an average individual policy is $500 per
month, skipping even 1 month makes
economic sense. Because preexisting
conditions cannot be used to deny
coverage, an individual can wait until he
or she is diagnosed with an illness. Other
than to cover a potential accident that
requires emergency room care, it does
not make economic sense to purchase
coverage. Even then, other insurance
(eg, automobile, homeowners) might
cover many of the potential accidents
that would require emergency room
care. Of course there are also strong
reasons to obtain health insurance - in
addition to satisfying the tax mandate,
qualified coverage provides both peace
of mind and rich benefits that help avoid
preventable conditions and maintain
health status.
It is worth noting that under the
Medicare Part D benefit, those who
decline to obtain coverage until they
need it pay a surcharge, making it less
economically beneficial to wait. This
disincentive to wait combined with the
fact that the eligible population is elderly
and more likely to require prescription
drugs on a regular basis has resulted in
close to universal adoption and far lower
than anticipated costs.
For employers, the economics are similar.
The tax incentive applies to firms with
more than 50 employees. Companies
that do not offer health insurance and
have at least 1 employee receiving
insurance subsidies must pay a tax of
$2000 per employee not covered by
insurance (excluding the first 30). For
example, a firm adding a 51st employee
would pay $42,000 in new annual taxes
plus an additional $2000. Effectively, a
company must view the new employee as
worth more than $42,000 in additional
net profit (over the amount needed to
justify the new employee in the first
place) or the cost of providing health
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coverage to all employees, a massive
disincentive for small businesses.
Employers are not required to pay an
assessment for employees who work less
than 30 hours per week or employees
hired for less than 120 days, seasonal
employees, or retail workers hired
exclusively during the holiday season.
Taken to extremes, the employer-related
mandates may lead to a system wherein
people are employed by smaller employers
or are employed on a part-time rather
than full-time basis. Current employees
or distinct components of businesses
would be spun off into smaller companies
or treated as independent contractors.
Large employers will need to make a
slightly different calculation - determine
the per-employee cost implications of
providing health coverage and compare
that cost to the cost of dropping the
plan, paying the penalty, and reimbursing
the employee for his or her employee
mandate fee. Employers with more than
200 employees must automatically enroll
all full-time employees as soon as they
are eligible. The Supreme Court did not
change this fundamental calculation but,
by upholding the law, it forced companies
to focus on the decision of whether or
not, or how, to provide health coverage for
employees. Because the first year of the
Employer Mandate is 2014, the decision
must be made in time for a benefits
selection process in the fall of 2013.
All larger employers must report, but not
tax, the cost of providing coverage on the
W-2 forms of employees. More highly
compensated employees are subject to
additional Medicare payroll taxes of 3.8%.
The new portion of the payroll tax will
be devoted to ACA implementation.
Smaller employers are entitled to grants
and other incentives to provide care and
will be eligible to obtain coverage through
the state HIEs.
(continued on page 8)
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Payers and Providers
Payer community support for the ACA
was based on an understanding that
the individual mandate would provide
millions of new lives to cover; therefore,
the mandatory essential benefit packages,
medical loss ratio, premium taxes,
guaranteed issue, and prohibition on
preexisting conditions and on annual and
lifetime benefits would be less pressing.
Nothing in the law prohibits health
plans from developing actuarially sound
premiums to cover those costs, and
nothing in the law actually limits costs.
Frankly, health plans make money on
each life and the higher the premium,
the higher the profit. If a problem exists,
it is with those individuals who obtain
coverage only when they need it - and
therein lies the rub of the Supreme Court
opinion for payers. Because the decision
makes it more likely that individuals will
not obtain coverage until they need it,
health plans will be unable to anticipate
reserves for such individuals, adding
uncertainty to the premium calculation.
And fewer individuals obtaining coverage
means less profit.
Because universal coverage was the
incentive for hospitals to accept

cuts in Medicare and Medicaid
reimbursement, hospitals will suffer.
The cuts include a 2% sequestration
across the board; reductions in market
basket updates for hospital care;
decreases in imaging reimbursement;
penalties for “potentially avoidable
readmissions”; Disproportionate Share
hospital reimbursement cuts; value-based
purchasing for cardiac, surgical, and
pneumonia services; hospital-acquired
condition penalties; and the bundling of
post-acute care services.
To the extent that states decide not
to expand Medicaid, and individual
and employer mandates do not lead to
anticipated increases in covered lives,
the Supreme Court decision likely will
have an adverse impact on hospitals. The
reduction in anticipated covered lives
and the willingness of Congress and the
Department of HHS to reconsider the
reductions will determine the extent of
the adversity.
Conclusion
Although the public and media focus on
the Supreme Court’s NFIB v. Sebelius
decision has been on determining
winners and losers, a far more interesting

dynamic is apparent. Inside Washington,
DC, the bill’s proponents and opponents
remain unchanged. Outside the
“Beltway,” the states, businesses, and
individuals dealing with the ACA are
focused less on the politics and more on
the financial, legal, and administrative
implications. The ACA is an ambitious
piece of legislation that covers a great
range of health care issues. Its attempt
to reach near universal coverage is a goal
to which there is almost no opposition,
yet the means to achieve it are incredibly
burdensome. The wisdom of the
Supreme Court’s decision is that it creates
the atmosphere for states to develop more
creative approaches and forces the issue
with respect to individuals obtaining
coverage. However unintended, the
decision is spurring a reconsideration of
the means to achieve universal coverage.
Howard A. Burde, Esq., is Principal of
Howard Burde Health Law, LLC. He can
be reached at: howard@burdelaw.com.
DISCLAIMER: This article does not
constitute legal advice. For advice on the
provisions of the ACA, please contact
your own attorney.

A Perspective: Through the Eye of the Beholder – Gauging Health Care Value
By Paul Wallace, MD
Introduction
Few concepts in health care have
promoted more discussion, prompted
more interventions, and sustained more
controversy than the desire to objectify
and measure value. Measures of diverse
attributes of value have multiplied
while conceptual and action-oriented
frameworks to position measurement
findings and to reconcile ambiguities
compete for attention. Refinement in
measure development and validation is

occurring in concert with generalized
agreement that the ability to robustly and
accurately measure attributes of value is
core to evolving and sustaining an effective
and equitable health system. However,
as the desire and ability to reflect aspects
of value has advanced, the importance of
linking the meaning of value to the needs
and beliefs of various key stakeholders in
the health care system also has escalated.
In short, the more we learn about
measuring value, the more there is yet

to learn about ensuring that the results
of measurement are broadly informative
and engaging. The following identifies
some considerations about, and current
gaps in, what may be involved in more
completely pursuing broadly engaging
value measurement and realization.
The Need to Create and Demonstrate Value…
Now, More Than Ever…
The importance of demonstrating the
value of health care services and delivery
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system change has intensified with the
passage of the Patient Protection and
Affordable Care Act (ACA) health reform
legislation in 2010, in combination with
the other extraordinary public investments
in the last decade in health services (eg,
the Medicare Prescription Drug Benefit
part of the 2003 Medicare Modernization
Act, elements of The American Recovery
and Reinvestment Act of 2009 and its
Health Information Technology for
Economic and Clinical Health Act).
A public focus of this amplified scrutiny is
the Centers for Medicare and Medicaid
Services’ Center for Medicare and
Medicaid Innovation, with its mission
of “Better health care, better health, and
reduced costs through improvement”1
coupled with an innovation investment
portfolio of several billion dollars. Other
contemporary examples include the
Patient-Centered Outcomes Research
Institute (PCORI), a private organization
created as part of health reform to promote
and support comparative effectiveness
research and patient-centered outcomes
research, with a planned public and private
annual funding stream of several hundred
million dollars, plus a wide range of
initiatives driven by private health plans,
care providers, and employers.2
Concurrently, defining and deriving
the “value” of health care services has
become substantially more complex as the
number and diversity of key stakeholders
has expanded. Attempts to reconcile
views of value are a mix of observed or
projected analytics to create clarity (and,
in some cases, even presumed “certainty”)
juxtaposed with major political debate and
substantial disagreement about the key
issues and goals that should be objectified.
Although data are increasingly abundant
and research and analytic tools have
become more sophisticated, it also has
become clear that the scope of value
determination as it has been practiced in

the past lacks generalizable application
across the emerging concerns of the
diverse set of stakeholders. More depth
and dimension are needed to fully
leverage the simple value equation of
V(value)=Q(quality)/C(cost).
For a concept as complex as value, the
evolution of its expanded meaning
and application in measurement and
prioritization of effort likely will require
multiple incremental changes. The
following 3 promising areas of important
augmentation to the current derivation of
“value” will be discussed and include:
• The importance of reflecting and
respecting multiple perspectives
•A
 ppreciating what we don’t know
about the care experience, and
•E
 mbracing that when there are
multiple aims for improvement, you
must address all concurrently.
The Importance of Perspective: “What
Will it Take for the Patient and Payer to
‘Get’ Value?”
A few years ago at the Kaiser Permanente
Care Management Institute, we
systematically sought out and engaged
groups of health system leaders,
clinicians, patients, and payers to better
understand how they perceived and
evaluated “value” in health care. Initially,
we wanted to know what would be
required for the consumer/patient and
employer/purchaser to understand
“quality” and “value” as we perceived
them from our perspective as managers
of a large integrated delivery system. We
saw value as best reflected by nested and
explicitly defined measures of health
care system structure, process, and
health outcomes such as the Healthcare
Effectiveness Data and Information Set
Quality Indicators.3 However, the more
complex value framework we eventually
derived (Figure 1) reflected and, perhaps
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more importantly, respected the differences
between key perspectives.
Figure 1. A Model of Health Care Value

Source: Bellows J, Sullivan MP. Could a quality index help us
navigate the chasm? http://xnet.kp.org/ihp/publications/docs/
quality_background.pdf. Accessed July 11, 2012.

Clinicians and health system leaders
most frequently associated value with
“traditional” metrics of clinical structure,
process, and health outcomes whereas
patients identified aspects of the
care experience, such as convenience,
respectful providers, and trusting
relationships with their clinicians,
as most critical for them in terms
of engagement and as meaningful
attributes of value.
Not surprisingly, organizations and
entities that provide payment for
services, including public payers, private
health plans, and major employers,
identified financial metrics - especially
affordability plus return on their healthassociated investments - as their leading
indicators of value. Importantly, no payer
suggested reducing costs by relaxing
clinical quality standards. Rather,
cost impact was generally identified
as attainable through improved
efficiency and reduction of waste. Each
stakeholder’s perspective recognized
and granted importance to the elements
valued by other stakeholder perspectives,
albeit with lower priority. However,
each stakeholder assigned prime “value”
to substantially different metrics. Each
stakeholder perspective did “get quality,”
but in its own manner.
(continued on page 10)
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Other efforts also have addressed the
impact of multiple perspectives on
value perception and definition. A
relatively encyclopedic consideration
of the complexity of the challenge has
recently been published by the Institute
of Medicine.4
Appreciating What We Don’t Know: The
Complex Nature of the Care Experience
Although patient-centeredness has
been positioned securely as a basic
element of quality, and hence value,
since the sentinel Institute of Medicine
quality reports of the last 2 decades,
measurement frameworks to robustly
reflect and capture a patient’s care
experience have been problematic. Most
recent progress has followed from the
leadership of the Agency for Healthcare
Research and Quality in developing and
promoting standardized patient surveys
such as the Consumer Assessment of
Healthcare Providers and Systems family
of instruments.5 Although the capability
for doing such surveys is a significant
achievement, additional complementary
approaches to better bridge other forms
of value-related measurement to the
patient experience are needed. Today’s
patients increasingly have multiple
clinicians, often receive care in multiple
locations, are responsible for major
portions of their care while at home,
and have little cohesion across settings
other than themselves and their families.
Consequently there is a need to move
beyond an exclusive focus on what can
be done to and for patients by providers
and a health system.
At a roundtable discussion of patientcenteredness among several California
and national health care leaders, the
successful patient experience was equated
with enabling patients to understand,
participate in, and direct their own care.
Examples included shared decision
making, use of personal health records
by patients and their clinicians, and

programs for palliative and end-of-life
care that require care decisions to be
highly customized for, and dependent
on, the patient and his or her family.6
Building from this discussion, a value
measurement framework that is
informative across the patient experience
should ideally include metrics that reflect:
•C
 are delivered for the patient
(eg, key prevention testing, case
management, much of chronic
condition management)
•C
 are delivered with the patient,
(eg, shared decision making,
care coordination)
•C
 are “delivered” by the patient and
his or her family, ideally with health
system support (eg, traditional selfcare, health behavior change, much
of end-of-life support).
In aggregate, a credible future value
framework will need to both respect
and reflect the varying loci of control for
different aspects of the pursuit of health
and delivery of health care.
The expanded national investment in
the PCORI achieved as part of the
ACA offers substantial leadership and
funding to better understand how to
engage and inform patients about their
care and care experience.
Addressing One Dimension of Value at
a Time Is Not Enough- The Integrating
Message of Concurrent Aims
The value model in Figure 1 is a close
analog of the Triple Aim proposed
by the Institute for Healthcare
Improvement (IHI) with its 3
overarching goals to be addressed in
pursuit of improved health system value.7
The IHI specific aims are to:
• Improve the health of the population;
• Enhance the patient experience of
care (including quality, access, and
reliability); and

• Reduce, or at least control, the per
capita cost of care.7
Very similar concepts – Better
Care, Affordable Care, and Healthy
People/Healthy Communities – now
form the framework for the National
Quality Strategy.8
The Triple Aim and National Quality
Strategy share a common core
concept: Meaningful and sustainable
value realization requires focused and
coordinated improvement addressing
all of the main dimensions of value
at the same time. It is insufficient to
focus exclusively on a single dimension
- whether it be cost, quality, or the
care experience - and expect the
other dimensions to fall into line. For
example, a common refrain in recent
years – “if quality is addressed then
cost improvement will follow” – has led
to initiatives that fail to identify and
pursue explicit timelines for addressing
cost issues. Quality, as observed by the
usual measures, has arguably improved
while an equivalent impact on cost
has remained on a future “to follow.”
Similarly, the cost-focused efforts of the
1990s failed to impact quality equally and
adversely affected the care experience.
The learning embodied in the Triple
Aim is that true progress toward higher
value health care requires progress in
multiple dimensions simultaneously,
with leadership and provider focus
on managing and reconciling the
inevitable conflicts and ambiguities
inherent in having goals embedded
in such a complex framework. As a
hopeful sign, a growing number of
organizations are now simultaneously
achieving improvement across these
multiple determinants of value. Common
traits across the diverse mix of payers
and providers achieving cross-cutting
improvement include:
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• Balance of system-based and
individual changes.
• New ways to engage both providers
and patients.
• Focus on population care.
• Use of health information technology.
Recently, others have provided
guidance about how to effectively focus
evaluations to gauge the full return on
these investments.9 The most useful
evaluations will be those that:
• Focus on change that matters.
• Document innovations to support
effective learning and dissemination.
• Balance flexibility and speed with
rigor in developing evidence to
support policy change.
Summary
As efforts to reform health care financing
and delivery intensify and come under
increased scrutiny by varied stakeholders,
gradual but significant progress is
being made in evolving a durable and

sustainable framework for measuring
value. Key aspects of this emerging
framework are respect for varying
perspectives of value and substantial
investments in better understanding and
characterizing all dimensions of value
- those most directly reflecting the care
experience in particular. A hopeful sign is
that a growing number of organizations
are achieving concurrent improvements
in multiple aspects of quality, cost,
and the patient care experience, and
the attributes and practices of these
leading groups are being successfully
characterized and spread.
Paul Wallace, MD, is Senior Vice
President and Director of the Center for
Comparative Effectiveness Research, The
Lewin Group. He can be reached at: paul.
wallace@Lewin.com.
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A Black Swan Comes to Philadelphia
By Jeffrey Brenner, MD
Have you ever wondered how the
US health care landscape will evolve
if, as some prefer, the system is not
subjected to reforms and warnings
about the consequences are ignored? I
have, and I fear that by 2017 we might
open our newspapers to read real
stories like this one.
Philadelphia Inquirer
3/20/2017
The President and CEO of Hamilton
University Hospital emerged today after
marathon discussions about the future of
the organization with an announcement

on the imminent closure of the 200-yearold hospital.

Hamilton will be the tenth academic health
center in a major US city to close this year.

Accompanied by the mayor, he spoke to
the large crowd of employees and local
Philadelphia leaders.

When asked about the growing trend, a
Brookings Institute health policy expert
said, “After a series of bailouts by the federal
government, the public appetite for rescuing
hospitals has diminished.”

“We’ve done everything we can,” he said.
“We’ll be shutting down by the end of the
month. I expect an orderly and safe process
to ensure that every patient receives the
highest quality of care until the last day.”
The mayor said, “The bondholders have
spoken and we are out of options. There are no
more bailouts coming for our city’s hospitals.”

In 2015, twenty-five large academic health
centers received federal loans through a
still controversial Presidential decision - a
rescue package totaling over $75 billion.
None of the loans are expected to be repaid
because the financial condition of the
hospitals has worsened.
(continued on page 12)
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An American Association of Retired
Persons spokesperson asked, “How can we
justify spending more precious Medicare
dollars on bailing out hospitals when
Medicare patients can’t find a primary care
provider to take care of them? Waiting lists
in cities like Philadelphia have grown into
the thousands for the average practice.”
A major bondholder for the hospital is
expected to lose over $350 million in the
closure of Hamilton University Hospital.
When asked about this significant
financial loss, its president said, “Events
like this are not predictable. Along
with the new management team at the
hospital, we did the best we could to turn
this around over the past year. But with
changes in federal funding there was no
way to make this work.”
The last few years have seen dramatic
reductions in National Institutes of
Health research spending, Medicare
reimbursements, and pharmaceutical
industry sponsorships, pushing many
academic health centers in the US to the
brink of bankruptcy. Most government
budget experts cite the unexpected attack
on American cities by foreign ecoterrorists, angry over rising sea levels, for
the current financial crisis in health care.
A well-known economist noted, “The US
economy was already in a weakened state
after years of unemployment, economic
stagnation, and political paralysis before
the attacks. Also, we just weren’t ready for
the tsunami of aging baby boomers. How
could we have known the number of new
expensive treatments that would come to
the marketplace?”
Struggling foreign relations haven’t
helped either, he added: “When the Chinese
stopped buying our bonds, it really closed
the door on our ability to keep bailing out
hospitals in the US.”

When a world famous but terminally
ill rock legend walked out of the ICU at
a leading New York hospital in 2014,
declaring that he would never die in a
hospital, he began a trend among baby
boomers that has spread quickly. The
growing natural death movement has had
an unexpected impact on the censuses in
American hospital ICUs.

At today’s press conference, nurses said they
offered concessions to keep Hamilton open.
“We made significant offers for voluntary cuts
to our wages and benefits. We did our part
but it wasn’t enough to save the hospital.”

One plan for the rescue of Hamilton
Hospital had been a buyout from a
large health insurance conglomerate. A
spokesperson for the company said in a
statement today, “We’ve bought over 20
academic health centers this year, but
the marketplace in Philadelphia is too
overcrowded. We couldn’t see a pathway to
profitability for this deal.”

Standing in front of Hamilton Hospital
as the announcement was made were
hundreds of residents and interns dressed
in white coats and scrubs. They looked
shocked as they realized their training
programs would be disbanded.

Some experts say the nation has not
seen this level of hospital closures since
the 1950s and 1960s, when financial
pressures forced states to shut psychiatric
hospitals in droves.
“Look what a mess we made when waves
of mentally ill patients were released from
psychiatric hospitals and overran urban
communities without adequate outpatient
services,” said a prominent US history
professor. “We are similarly unprepared for
the consequences of deinstitutionalizing
medical care in our country today.”
The closure of Hamilton Hospital is
expected to have painful consequences
for a city already reeling from record
unemployment, falling housing prices,
and significant reductions in student
enrollment at the city’s flagship
educational institution.
“The Eds and Meds model is over,” said
a spokesperson for Philadelphia’s business
community. “Philadelphia needs to find a
new economic driver.”

In the last 4 years many nurses across the
US have shifted from working in hospitals
to home-based care.

A fourth-year surgery resident said, “All
of us have over $400,000 in loans. If we
can’t finish our training how will we ever
pay off this debt? With the increasing
number of hospital closures across the
country, there are no more residency slots
available. Now I might be headed abroad
to finish my training.”
A growing number of hospitals in foreign
countries have begun to recruit American
medical school graduates and trainees to
complete their training. With the closure of
places like Hamilton Hospital this trend is
expected to accelerate.
The “news item” might go on, but the
message should already be clear. Without
willingness to recognize these enormous
problems and their consequences – and
without a collective commitment to
change – it is certainly possible that we
will be faced with this type of scenario in
the not-too-distant future.
Jeffrey Brenner, MD is Founder and
Executive Director of the Camden
Coalition of Healthcare Providers. He can
be reached at: Jeffrey.brenner@verizon.net.
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